Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Initial Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01076751
What this trial is testing

Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) Patients

Who this might be right for
Prostatic Neoplasms
Sanofi 82
Not applicableStudy completedNCT01843764
What this trial is testing

Rapid Diagnostic Tests for Assessment of Initial Clearance and Detection of Recurrent Malaria Infections

Who this might be right for
Plasmodium Falciparum Malaria
Anders Björkman 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT05585580
What this trial is testing

Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior Immunotherapy

Who this might be right for
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Qilu Hospital of Shandong University 59
Large-scale testing (Phase 3)Looking for participantsNCT06607796
What this trial is testing

Efficacy and Safety of Intratumoral Toluenesulfonamide (PTS) Injection in Stage IV Driver Gene-Negative NSCLC With/Without Chemoimmunotherapy

Who this might be right for
Lung Cancer
Zhou Chengzhi 180
Testing effectiveness (Phase 2)Looking for participantsNCT07398326
What this trial is testing

Anlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Shanghai Changzheng Hospital 37
Early research (Phase 1)Study completedNCT01428297
What this trial is testing

A Study Evaluating the Safety and Efficacy of Topical BPR277 for the Treatment of Atopic Dermatitis and Netherton Syndrome

Who this might be right for
Healthy VolunteersAtopic DermatitisNetherton Syndrome
Novartis Pharmaceuticals 12
Testing effectiveness (Phase 2)Study completedNCT00411424
What this trial is testing

Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 54
Not applicableUnknownNCT06052280
What this trial is testing

Pilot Study: Parkinson's Conventional Physiotherapy vs Home-based Telerehabilitation

Who this might be right for
Parkinson Disease
Azienda Sanitaria Locale CN1 Cuneo 40
Testing effectiveness (Phase 2)UnknownNCT03700359
What this trial is testing

Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC

Who this might be right for
Small Cell Lung Carcinoma
The First Affiliated Hospital of Guangzhou Medical University 60
Testing effectiveness (Phase 2)UnknownNCT04098796
What this trial is testing

PD-1 Antibody + XELOX in 1st Line Serum A-fetoprotein (AFP)-Elevated Gastric or Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Gastric or Gastroesophageal Junction AdenocarcinomaAFP
China Medical University, China 30
Testing effectiveness (Phase 2)Study completedNCT01524991
What this trial is testing

First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Hoosier Cancer Research Network 36
Testing effectiveness (Phase 2)Study completedNCT02061085
What this trial is testing

Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment

Who this might be right for
Breast NeoplasmMetastasis
MedSIR 53
Testing effectiveness (Phase 2)UnknownNCT05608785
What this trial is testing

Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes

Who this might be right for
Gastric CancerGastroesophageal-junction Cancer
Henan Cancer Hospital 45
Testing effectiveness (Phase 2)Ended earlyNCT00194935
What this trial is testing

Weekly Topotecan Therapy in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Weill Medical College of Cornell University 32
Not applicableLooking for participantsNCT07551050
What this trial is testing

Real-world Patient-reported Outcome of Sacituzumab Govitecan in Chinese Metastatic Breast Cancer

Who this might be right for
TNBC - Triple-Negative Breast Cancer
Fudan University 300
Large-scale testing (Phase 3)Active Not RecruitingNCT07196774
What this trial is testing

A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Advanced HER2-positive Breast Cancer

Who this might be right for
Early-stage or Locally Advanced HER2-positive Breast Cancer
Jiangsu HengRui Medicine Co., Ltd. 740
Not applicableEnrolling By InvitationNCT06567496
What this trial is testing

Effects of a Virtual Reality Intervention on Mental Health Outcomes and Academic Success in Physical Therapy Students

Who this might be right for
Mental StressAnxietyDepression+1 more
Belmont University 23
Testing effectiveness (Phase 2)UnknownNCT05738317
What this trial is testing

Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel in Non-squamous NSCLC After First-line Treatment

Who this might be right for
Non-small Cell Lung Cancer
Xiaorong Dong 45
Large-scale testing (Phase 3)Looking for participantsNCT07315750
What this trial is testing

Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

Who this might be right for
Gastric Carcinoma
RemeGen Co., Ltd. 555
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07293546
What this trial is testing

Phase 1/2 Study of FRF-001, an AAV-9 Gene Therapy, in Patients With FOXG1 Syndrome (FS)

Who this might be right for
FOXG1 Syndrome
FOXG1 Research Foundation 12
Next Page